Sponsor:
University of Virginia
Code:
NCT01893060
Conditions
Line Insertion Site
Central Line-associated Bloodstream Infection (CLABSI)
Eligibility Criteria
Sex: All
Age: 0
Healthy Volunteers: Not accepted
Interventions
Povidone-Iodine
Chlorhexidine gluconate
Pluronic Cream
control
Brief summary:
Conditions
Line Insertion Site
Central Line-associated Bloodstream Infection (CLABSI)
Study ID
NCT01893060
Start date
Jul, 2013
Status verified date
Aug, 2013
Completion date
Jul, 2014
Anticipated
Primary completion date
May, 2014
Anticipated
Eligibility Criteria
Sex: All
Age: 0
Healthy Volunteers: Not accepted
Enrollment
100 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Prevention
Arms
experimental: Povidone-Iodine
experimental: Chlorhexidine
experimental: Pluronic Cream
sham comparator: Control
Interventions
Povidone-Iodine
Chlorhexidine gluconate
Pluronic Cream
control
Primary outcome measure
Central contacts
Locations
University of Virginia HealthSystem
Recruiting
Charlottesville, Virginia, United States, 22932
Contacts
Sponsor
University of Virginia
Last update posted
Aug 2, 2013
Last verified
Aug, 2013
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by University of Virginia on 2013-08-02.